Skip to main content

O'Day Daniel Patrick's Form 4 filing

Gilead Sciences, Inc.GILD · filed Nov 2, 2026

Accession no.
0001638643-26-000038
Filed
Nov 2, 2026, 7:14 PM ET
Trade date
Oct 30-Nov 2, 2026
Filing delay
3 days
Rule 10b5-1 plan
Checked

This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.33M. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
O'Day Daniel PatrickCIK 0001638643Director, Officer (Chairman & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 30, 2026Common StockMOption exerciseAcquired+15,881$72.34+$1,148,831.54582,564Direct
Oct 30, 2026Common StockSSaleDisposed−15,881$175.25F2−$2,783,075.37566,683Direct
Nov 2, 2026Common StockSSaleDisposed−1,600$167.40F3−$267,839.84565,083Direct
Nov 2, 2026Common StockSSaleDisposed−1,700$168.10F4−$285,771.02563,383Direct
Nov 2, 2026Common StockSSaleDisposed−1,904$169.27F5−$322,296.36561,479Direct
Nov 2, 2026Common StockSSaleDisposed−7,796$170.35F6−$1,328,069.65553,683Direct
Nov 2, 2026Common StockSSaleDisposed−2,000$171.06F7−$342,125.4551,683Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 30, 2026Common StockMOption exerciseDisposed−15,881$0.00$0240,739Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Sale prices for the transactions reported range from $175.05 to $175.45. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

Referenced by the price of 1 transaction in Table I.

F3

Sale prices for the transactions reported range from $166.69 to $167.66. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

Referenced by the price of 1 transaction in Table I.

F4

Sale prices for the transactions reported range from $167.72 to $168.68. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

Referenced by the price of 1 transaction in Table I.

F5

Sale prices for the transactions reported range from $168.78 to $169.77. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

Referenced by the price of 1 transaction in Table I.

F6

Sale prices for the transactions reported range from $169.83 to $170.82. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

Referenced by the price of 1 transaction in Table I.

F7

Sale prices for the transactions reported range from $170.83 to $171.27. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)